NCT01772472 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 743
- group Id
- BG001
- value
- 743
- group Id
- BG002
- value
- 1486
- units
- Participants
- groups
- description
- Participants received trastuzumab, 6 mg/kg, IV, Q3W, as a maintenance dose for 14 cycles (1 cycle = 21 days) or until disease recurrence or unacceptable toxicity which ever occurs first.
- id
- BG000
- title
- Trastuzumab
- description
- Participants received trastuzumab emtansine, 3.6 mg/kg, IV, Q3W for 14 cycles (1 cycle = 21 days) or until disease recurrence or unacceptable toxicity which ever occurs first.
- id
- BG001
- title
- Trastuzumab Emtansine
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- <=18 years
- measurements
- group Id
- BG000
- value
- 675
- group Id
- BG001
- value
- 685
- group Id
- BG002
- value
- 1360
- title
- Between 18 and 65 years
- measurements
- group Id
- BG000
- value
- 68
- group Id
- BG001
- value
- 58
- group Id
- BG002
- value
- 126
- title
- >=65 years
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Categorical
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 740
- group Id
- BG001
- value
- 741
- group Id
- BG002
- value
- 1481
- title
- Female
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 5
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 107
- group Id
- BG001
- value
- 91
- group Id
- BG002
- value
- 198
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 543
- group Id
- BG001
- value
- 579
- group Id
- BG002
- value
- 1122
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 93
- group Id
- BG001
- value
- 73
- group Id
- BG002
- value
- 166
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 50
- group Id
- BG001
- value
- 36
- group Id
- BG002
- value
- 86
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 64
- group Id
- BG001
- value
- 65
- group Id
- BG002
- value
- 129
- title
- Asian
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 19
- group Id
- BG001
- value
- 21
- group Id
- BG002
- value
- 40
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 530
- group Id
- BG001
- value
- 551
- group Id
- BG002
- value
- 1081
- title
- White
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 3
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 77
- group Id
- BG001
- value
- 69
- group Id
- BG002
- value
- 146
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- population Description
- Intent-to-treat (ITT) population included all participants who were randomized to the study regardless of whether they received any study treatment.
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 743
- group Id
- BG001
- value
- 743
- group Id
- BG002
- value
- 1486
- units
- Participants
- groups
- description
- Participants received trastuzumab, 6 mg/kg, IV, Q3W, as a maintenance dose for 14 cycles (1 cycle = 21 days) or until disease recurrence or unacceptable toxicity which ever occurs first.
- id
- BG000
- title
- Trastuzumab
- description
- Participants received trastuzumab emtansine, 3.6 mg/kg, IV, Q3W for 14 cycles (1 cycle = 21 days) or until disease recurrence or unacceptable toxicity which ever occurs first.
- id
- BG001
- title
- Trastuzumab Emtansine
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- <=18 years
- measurements
- group Id
- BG000
- value
- 675
- group Id
- BG001
- value
- 685
- group Id
- BG002
- value
- 1360
- title
- Between 18 and 65 years
- measurements
- group Id
- BG000
- value
- 68
- group Id
- BG001
- value
- 58
- group Id
- BG002
- value
- 126
- title
- >=65 years
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Categorical
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 740
- group Id
- BG001
- value
- 741
- group Id
- BG002
- value
- 1481
- title
- Female
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 5
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 107
- group Id
- BG001
- value
- 91
- group Id
- BG002
- value
- 198
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 543
- group Id
- BG001
- value
- 579
- group Id
- BG002
- value
- 1122
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 93
- group Id
- BG001
- value
- 73
- group Id
- BG002
- value
- 166
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 50
- group Id
- BG001
- value
- 36
- group Id
- BG002
- value
- 86
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 64
- group Id
- BG001
- value
- 65
- group Id
- BG002
- value
- 129
- title
- Asian
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 19
- group Id
- BG001
- value
- 21
- group Id
- BG002
- value
- 40
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 530
- group Id
- BG001
- value
- 551
- group Id
- BG002
- value
- 1081
- title
- White
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 3
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 77
- group Id
- BG001
- value
- 69
- group Id
- BG002
- value
- 146
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- population Description
- Intent-to-treat (ITT) population included all participants who were randomized to the study regardless of whether they received any study treatment.
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle